Similarities in the presentation of fibromyalgia and long COVID may mean rheumatologists will be faced with increasing numbers of patients whom they are “powerless to help”, experts have warned.
In a series of letters debating the resemblance of long COVID symptoms to fibromyalgia, rheumatologists have questioned what role the profession should play in managing patients and whether they should form part of a multi-disciplinary team with psychologists, chronic pain and rehabilitation specialists.
It comes in response to a paper published last year in the Annals of the Rheumatic Diseases which argued that with long COVID, medicine is repeating mistakes that were made in trying to define the pathophysiology of fibromyalgia while ignoring psychosomatic factors.
To address this, Professor Xavier Mariette from Université Paris-Saclay, France, suggested renaming long COVID as fibromyalgia-like post-COVID syndrome.
A response from Professor Robert Landewe from the Amsterdam Rheumatology Center in the Netherlands published in the same journal noted that rheumatologists are still “relatively powerless” in managing patients with fibromyalgia who may face long waits to be seen.
Agreeing with the similarities between fibromyalgia and long COVID, he added that recognising this problem does not solve the practical problems and challenges it raises for rheumatologists.
In fact, considering both as “ill-defined psychosomatic disorders with one ‘final common pathway’”, that can be triggered by different causes including common viruses, “bears the danger of putting the rheumatologist in the forefront of the societal long-COVID problem”, he said.
“Patients with long-COVID will consult us (even) more often and ask for solutions that we cannot offer.